Rezultati pretraživanja
  1. 31. sij

    Is meeting with Piper Sandler (M&A specialist) in London and Switzerland to do a possible $85+ buyout deal from Nestle (owns 19%) upon FDA approval?🌕🤑💯🙌🚀

    9 replies 9 proslijeđenih tweetova 19 korisnika označava da im se sviđa
  2. 31. sij

    FDA Approves PALFORZIA™ as First Treatment for Peanut Allergy

    41 proslijeđeni tweet 71 korisnik označava da mu se sviđa
  3. prije 12 sati

    I love those days I make a nice little sum while I'm away from my desk. Series of doctors today, but I am very pleased with an over 4% return on my money. Sure, has retreated some, but the smart money isn't moving. Even the analysts see the opportunity here.

    1 proslijeđeni tweet 13 korisnika označava da im se sviđa
  4. 1. velj

    MONDAY Feb 3 meeting with Piper Sandler (M&A) in London and TUESDAY Feb 4 in Zurich (Switzerland) - I guess talking about buyout deal from Nestle (owns already 19%). Palforzia sales could hit $1 billion by 2026 = b...

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
  5. prije 2 sata
    Odgovor korisnicima

    They’ve already lined up 80% of who treat.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  6. prije 7 sati

    NEW ARTICLE : FDA Approves First Drug for Peanut Allergy Get all the latest related news here :

  7. prije 11 sati

    P/L: +$382.18 got on the wrong side of but was able to make back and go green on the day with shorting pops on the other crap -

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
  8. prije 15 sati

    Where will be by EOD?

    1 korisnik označava da mu se sviđa
  9. prije 16 sati

    asset watch- active in premarket trading -

    Working for you!
    An experienced attorney dedicated to seeing our clients score the wins.
  10. prije 17 sati

    I have to a doctor's appointment this morning, so I'll be out of pocket for half the day. Good luck everyone. Market's are up and was approved!

    5 replies 19 korisnika označava da im se sviđa
  11. 2. velj

    I’m holding my feb calls till Wednesday. If spikes to 50 tomorrow will pull out my investment (48k) and ride the rest, hoping for buyout by mid feb. unless it spikes past 65-70 then I’ll sell it all. I may also open March or July calls to roll

    1 reply 2 korisnika označavaju da im se sviđa
  12. 2. velj

    this a chart for Monday showing the open at 37 and climb to 70+.

    1 reply 4 korisnika označavaju da im se sviđa
  13. 2. velj

    over 11 mio. shares short + fda approval with natonal news covering it all wekend + potential nestlé buyout in the air + all time high of $40.65 Jan 2018 = I expect epic short squeeeeeze tomorrow with the opening bell (not premarket)!!

    1 proslijeđeni tweet 8 korisnika označava da im se sviđa
  14. 2. velj

    There are only 46.3 million share in the float and of that amount, 24.87% (11.5 million) are sold short. Seems like an potential squeeze set-up if "the powers that be" want to make it happen.

    4 korisnika označavaju da im se sviđa
  15. 2. velj

    Peanut Allergy medicine makes prime time ABC news after FDA. This will be a huge indication.

    6 korisnika označava da im se sviđa
  16. 1. velj
    Odgovor korisnicima

    Gentlemen; is only ONE indication has in the pipeline. Also working on dairy, eggs, etc....$55 is absolutely in the cards.

    3 korisnika označavaju da im se sviđa
  17. 1. velj

    Break of $39.71 is the big spot. Looks like a "BUY the news" situation here--not sell the news. This kind of press is so widespread and with so many shorts under water after a Friday afternoon FDA approval PR...

    1 reply 3 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
  18. 1. velj

    $36 to $31 to $36 on Approval - .

    1 proslijeđeni tweet 6 korisnika označava da im se sviđa
  19. 1. velj
    Odgovor korisniku/ci

    $50 for a 51% stake of company. Lets crunch@

    2 korisnika označavaju da im se sviđa
  20. 1. velj

    additional drugs in the pipeline. Nestle would be purchasing other assets

    1 reply 3 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.